Akèy › Kansè (tout kalite) › Florid › Orlando
Etid klinik pou Kansè (tout kalite) nan Orlando, FL
24 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Registry Study for Radiation Therapy Outcomes
Ap rekriteEtid obsèvasyon
- Orlando Health Cancer Institute, Orlando
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- GSK Investigational Site, Reunion · 23 mi lwen
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Ap rekriteFaz 3
- Advent Health, Orlando
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 3
- Orlando Health Cancer Institute /ID# 280418, Orlando
Visugromab in Cachexia International Trial
Ap rekriteFaz 2/3
- Clermont Oncology Center, Clermont · 24 mi lwen
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Orlando Health Cancer Institute, Orlando
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Ap rekriteFaz 2
- Clermont Oncology Center ( Site 0041), Clermont · 24 mi lwen
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Advent Health - Orlando, Orlando
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- AdventHealth Orlando, Orlando
- Arnold Palmer Hospital for Children, Orlando
- Nemours Children's Hospital, Orlando
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- AdventHealth Celebration, Celebration · 17 mi lwen
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Ap rekriteFaz 3
- Orlando Health Cancer Institute, Orlando
- Health Central, Ocoee · 10 mi lwen
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Ap rekriteFaz 1/2
- Clermont Oncology Center, Clermont · 24 mi lwen
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Orlando Health UF Health Cancer Center, Orlando
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Ap rekriteFaz 1
- GSK Investigational Site, Orlando
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Ap rekriteFaz 1/2
- Orlando Health Cancer Institute, Orlando
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Ap rekriteFaz 1
- Research Site, Orlando
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Ap rekriteFaz 2
- Clermont Oncology Center, Clermont · 24 mi lwen
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
Ap rekrite
- Orlando Health, Orlando
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- AdventHealth Cancer Institute, Celebration · 17 mi lwen
GEMINI-NSCLC: NSCLC Biomarker Study
Ap rekriteEtid obsèvasyon
- Clermont Oncology Center, Clermont · 24 mi lwen
Beat Childhood Cancer Specimen Banking and Data Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Arnold Palmer Hospital for Children, Orlando
Caris Biorepository Research Protocol
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Advent Health, Orlando
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Ap rekriteEtid obsèvasyon
- AdventHealth Cancer Institute, Orlando
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
Ap rekriteEtid obsèvasyon
- University of Central Florida, Orlando
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan Orlando
- Kansè Poumon ki pa ti selil44 etid
- Obèsite31 etid
- Kansè Metastatik29 etid
- Sipwa27 etid
- Maladi Alzheimer25 etid
- Dyabèt Tip 224 etid
- Kansè nan tete23 etid
- Kansè ovè22 etid
- Kolit Ulseratif22 etid
- Kansè poumon21 etid
- Kansè kolorektal19 etid
- Twoub depresif majè19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.